A Comparison of Mood Improvements Following a Single Infusion of an N-methyl-D-aspartate (NMDA) Antagonist in Treatment-Resistant Patients with Anxious and Non-Anxious Depression

被引：0

|

作者：

Ionescu, Dawn F. ^{[1
]}

Luckenbaugh, David A. ^{[1
]}

Slonena, Elizabeth E. ^{[1
]}

Niciu, Mark J. ^{[1
]}

Richards, Erica M. ^{[1
]}

Zarate, Carlos A. ^{[1
]}

机构：

[1] NIMH, NIH, Bethesda, MD 20892 USA

来源：

BIOLOGICAL PSYCHIATRY | 2014年 / 75卷 / 09期

关键词：

Anxious Depression; Ketamine; Treatment Resistant Depression;

D O I：

暂无

中图分类号：

Q189 [神经科学];

学科分类号：

071006 ;

摘要：

397

引用

收藏

页码：127S / 128S

页数：2

相关论文

共 42 条

[41] Comments on "An Innovative Design to Establish Proof of Concept of the Antidepressant Effects of the NR2B Subunit Selective N-Methyl-D-Aspartate Antagonist, CP-101,606, in Patients With Treatment-Refractory Major Depressive Disorder" Reply
Preskorn, Sheldon H.
Baker, Bryan
Kolluri, Sheela
Menniti, Frank S.
Krams, Michael
Landen, Jaren W.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2009, 29 (04) : 412 - 412
[42] A Phase Ib Randomized Controlled Study to Evaluate the Effectiveness of a Single-Dose of the NR2B Selective N-Methyl-d-Aspartate Antagonist MK-0657 on Levodopa-Induced Dyskinesias and Motor Symptoms in Patients With Parkinson Disease
Herring, W. Joseph
Assaid, Christopher
Budd, Kerry
Vargo, Ryan
Mazenko, Ralph S.
Lines, Christopher
Ellenbogen, Aaron
Metman, Leo Verhagen
CLINICAL NEUROPHARMACOLOGY, 2017, 40 (06) : 255 - 260

← 1 2 3 4 5 →